510 K COALITION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2010–2014

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	5	1
2010	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FAEGRE BAKER DANIELS CONSULTING	—	21

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	14
SENATE	14
Food & Drug Administration (FDA)	4

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	11
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	4

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 510111th Congress

FDA Food Safety Modernization Act

Cited source text and reported amounts

FDA's 510 (K) review process for medical devices; reauthorization of Medical Devise User Fee ACt (MDUFA)

Client expense: — · Firm income: —

Matched citations: s 510

510 K COALITION — Lobbying Disclosure | Poliscope